MBRX - Moleculin Biotech GAAP EPS of -$2.02
2024-05-13 07:44:05 ET
More on Moleculin Biotech
- Moleculin Biotech, Inc. (MBRX) Q4 2023 Earnings Call Transcript
- Moleculin's acute myeloid leukemia treatment gets EMA's orphan drug designation
- Moleculin gets U.S. patent issue notification for annamycin targeting unmet need in AML
- Seeking Alpha’s Quant Rating on Moleculin Biotech
- Historical earnings data for Moleculin Biotech